Exscientia Holdings Limited (EXAI) Social Stream
EXSCIENTIA PLC (EXAI) Price Targets From Analysts
Use the tables below to see what analysts covering EXSCIENTIA PLC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-30 | 2 | $27 | $25 | $26 | $6.41 | 305.62% |
| 2022-01-07 | 2 | $25 | $25 | $25 | $6.41 | 290.02% |
| 2022-01-31 | 2 | $25 | $20 | $22.5 | $6.41 | 251.01% |
| 2022-04-11 | 2 | $25 | $21 | $23 | $6.41 | 258.81% |
| 2022-04-18 | 3 | $21 | $20 | $20.5 | $6.41 | 219.81% |
| 2022-05-24 | 3 | $21 | $20 | $20.333 | $6.41 | 217.21% |
| 2022-08-13 | 3 | $20 | $20 | $20 | $6.41 | 212.01% |
| 2022-08-23 | 3 | $20 | $16 | $18.666 | $6.41 | 191.2% |
| 2022-08-24 | 3 | $20 | $16 | $18 | $6.41 | 180.81% |
| 2022-10-17 | 3 | $20 | $15 | $17 | $6.41 | 165.21% |
| 2023-02-13 | 4 | $20 | $12 | $15.75 | $6.41 | 145.71% |
| 2023-04-24 | 4 | $20 | $12 | $15.5 | $6.41 | 141.81% |
| 2023-06-06 | 3 | $16 | $12 | $14 | $6.41 | 118.41% |
| 2023-07-20 | 4 | $16 | $12 | $14 | $6.41 | 118.41% |
| 2023-08-29 | 4 | $16 | $12 | $13.75 | $6.41 | 114.51% |
| 2023-10-03 | 4 | $14 | $11 | $12.5 | $6.41 | 95.01% |
| 2023-10-10 | 4 | $13 | $7 | $10.75 | $6.41 | 67.71% |
| 2023-12-19 | 4 | $13 | $7 | $10.25 | $6.41 | 59.91% |
The Trend in the Analyst Price Target
Over the past 47 weeks, EXAI's average price target has gone down $5.5.
EXAI reports an average of 107.3% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-24 | 4 | 20 | 12 | 15.50 | 5.13 | 202.14% |
| 2023-06-05 | 3 | 16 | 12 | 14.00 | 7.69 | 82.05% |
| 2023-10-03 | 4 | 14 | 11 | 12.50 | 4.59 | 172.33% |
| 2023-10-10 | 4 | 13 | 7 | 10.75 | 4.66 | 130.69% |
| 2023-12-19 | 4 | 13 | 7 | 10.25 | 6.75 | 51.85% |
EXAI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 3 | 0 | 1 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
EXAI's average broker recommendation rating improved by 0 over the prior 48 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, EXSCIENTIA PLC's number of analysts covering the stock is higher than 172.61% of them.
- EXSCIENTIA PLC's upside potential (average analyst target price relative to current price) is greater than 1708.87% of stocks in the mid market cap category.
- In the context of Pharmaceutical Products stocks, EXSCIENTIA PLC's variance in analysts' estimates is lower than -194% of them.
- In the context of stocks in the mid market cap category, EXSCIENTIA PLC's average analyst price target is higher than 488.11% of them.
Stocks similar to EXSCIENTIA PLC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CLDX, ZNTL, and IGMS.
View All Top Stocks by Price Target
What is the outlook for EXAI? Use POWR Ratings for clearer insight into price direction.